Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

73.03
Delayed Data
As of Feb 12
 +0.26 / +0.36%
Today’s Change
58.06
Today|||52-Week Range
110.68
-19.11%
Year-to-Date

Today’s Trading

Previous close72.77
Today’s open73.44
Day’s range70.75 - 74.37
Volume860,870
Average volume (3 months)690,718
Market cap$3.1B
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+1,372.22%
Earnings growth (this year)-73.88%
Earnings growth (next 5 years)+24.50%
Revenue growth (last year)+25.41%
P/E ratio25.9
Price/Sales13.32
Price/Book10.32

Competitors

 Today’s
change
Today’s
% change
MRMindray Medical Inte...+0.03+0.11%
WSTWest Pharmaceutical ...+0.54+0.99%
GMEDGlobus Medical Inc+0.21+0.94%
IARTIntegra LifeSciences...-0.04-0.07%
Data as of 4:02pm ET, 02/12/2016

Financials

Next reporting dateApril 28, 2016
EPS forecast (this quarter)$0.17
Annual revenue (last year)$230.3M
Annual profit (last year)$113.7M
Net profit margin49.36%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts

Partner Offers